lactobacillus fermentum

Cell therapyexperimental

Limosilactobacillus fermentum is a Gram-positive species in the heterofermentative genus Limosilactobacillus. It is associated with active dental caries lesions. It is also commonly found in fermenting animal and plant material including sourdough and cocoa fermentation. Some strains of lactobacilli formerly mistakenly classified as L. fermentum have since been reclassified as Limosilactobacillus reuteri. — Wikipedia

Clinical trial activity

17 trials · 25 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Jan 1, 2005 (NCT00256087)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lactobacillus fermentin
  • lactobacillus fermentum
  • lactobacillus fermentum cect5716
  • lactobacillus fermentum gm-090
  • lactobacillus fermentum lc40
  • lactobacillus fermentum vri 003
  • l. fermentum

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05527301Phase 2Oct 14, 2022HEM Pharma Inc., Premier Research Group
NCT05467605N/AJul 31, 2022Cairo University
NCT04167995Early Phase 1 (Phase 1)Nov 9, 2019Ain Shams University
NCT05076656Early Phase 1 (Phase 1)Jun 10, 2019Government of Spain, University of Malaga
NCT03940612N/AMay 1, 2019Synbio Tech, University of Science Malaysia
NCT04032899N/AApr 15, 2019Biosearch S.A., University of Granada
NCT03467334Phase 2May 31, 2017Biosearch S.A., European Regional Development Fund, Government of Spain, University of Granada
NCT03539263N/ADec 20, 2016Probiotical S.p.A., University of Verona
NCT02203877N/AAug 1, 2013Biosearch S.A.
NCT01635738N/ADec 1, 2011GenMont Biotech Incorporation, Government of Taiwan
NCT02093338N/AJul 1, 2011Biosearch S.A., University of Granada
NCT03204630N/AJan 31, 2011Andaluz Health Service, Biosearch S.A., Universidad de Cordoba
NCT00716183Phase 2/Phase 3 (Phase 3)Jul 1, 2008Universidad Complutense de Madrid
NCT01215656Phase 2/Phase 3 (Phase 3)May 1, 2008Puleva Biotech
NCT01409668Phase 1Sep 1, 2007Micropharma Limited, University of Manitoba
NCT00294788Phase 1/Phase 2 (Phase 2)Mar 1, 2006Good Health Solutions, Probiomics Ltd
NCT00256087N/AJan 1, 2005Melbourne Health, University of Melbourne
Showing 17 of 17 trials
Page 1 / 1

Organizations

Research & Development (25)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Biosearch S.A.For profit5522011
University of GranadaAcademic/Hospital3022011
Government of SpainGovernment2122017
Ain Shams UniversityAcademic/Hospital1112019
Andaluz Health ServiceAcademic/Hospital1012011
Cairo UniversityAcademic/Hospital1112022
European Regional Development FundAcademic/Hospital1012017
GenMont Biotech IncorporationFor profit1112011
Good Health SolutionsAcademic/Hospital1012006
Government of TaiwanGovernment1012011
HEM Pharma Inc.For profit1112022
Melbourne HealthAcademic/Hospital1112005
Micropharma LimitedFor profit1012007
Premier Research GroupFor profit1012022
Probiomics LtdFor profit1112006
Probiotical S.p.A.For profit1112016
Puleva BiotechFor profit1112008
Synbio TechFor profit1012019
Universidad Complutense de MadridAcademic/Hospital1112008
Universidad de CordobaAcademic/Hospital1012011
25 organizations
Page 1 / 2